OTR Global upgraded its view of Edwards Lifesciences to Positive from Mixed.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EW:
- Edwards Lifesciences price target raised to $103 from $95 at Morgan Stanley
- Edwards Lifesciences price target raised to $100 from $93 at Oppenheimer
- Early notable gainers among liquid option names on March 14th
- Micron upgraded, Foot Locker downgraded: Wall Street’s top analyst calls
- Edwards Lifesciences upgraded to Buy at BofA after ‘bullish’ management meetings